A global study of 525 patients found no survival benefit from pentoxifylline in treating alcohol-associated hepatitis with acute kidney injury: “Pentoxifylline use was not associated with survival.”
Over one-third of psoriasis patients had elevated hs-CRP despite biologic treatment and skin clearance, with obesity, female sex, and fatty liver disease identified as key predictors of residual inflammation.
A 3-year study found that most patients with moderate to severe ulcerative colitis who responded to initial upadacitinib treatment stayed in remission through 96 weeks, with manageable side effects and consistent results across dosage groups.
A randomized trial of 248 hospitalized patients with alcohol use disorder found no significant difference in drinking reduction between oral and injectable naltrexone.
Researchers found that vitamin B12 reduced cell death in the pancreas and improved energy levels in mouse models of acute pancreatitis, suggesting a potential protective role.